Effects of Oral L-Carnitine on Liver Functions after Transarterial Chemoembolization in Intermediate-Stage HCC Patients

Figure 2

L-carnitine effects on PT and total bilirubin. (a) L-carnitine effects on mean PT changes from baseline in study patients overall. (b) L-carnitine effects on mean PT changes from baseline in BCAA+ patients. (c) L-carnitine effects on mean total bilirubin changes from baseline in study patients overall. (d) L-carnitine effects on mean total bilirubin changes from baseline in BCAA− patients. Footnote: PT: prothrombin time; TACE: transarterial chemoembolization. Error bars represent standard errors.

(a)

(b)

(c)

(d)